PPARγ inhibits HMGB1 expression through upregulation of miR-142-3p in vitro and in vivo

被引:31
|
作者
Yuan, Zhiqiang [1 ]
Luo, Gaoxing [1 ]
Li, Xiaolu [1 ]
Chen, Jing [1 ]
Wu, Jun [1 ]
Peng, Yizhi [1 ]
机构
[1] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Southwest Hosp, Inst Burn Res, Chongqing 400038, Peoples R China
关键词
PPAR gamma; miR-142-3p; HMGB1; Inflammation; GROUP BOX 1; NF-KAPPA-B; ACTIVATED-RECEPTOR-DELTA; INFLAMMATORY DISEASE; TUMOR-SUPPRESSOR; IMMUNE-SYSTEM; LATE MEDIATOR; CELL-DEATH; MICRORNAS; RELEASE;
D O I
10.1016/j.cellsig.2015.12.013
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Peroxisome proliferator-activated receptor gamma (PPAR gamma) belongs to the nuclear receptor superfamily and it has received much attention because of its anti-inflammatory activity. However, the underlying molecular mechanism is not completely understood. In the present study, we demonstrated that the level of PPAR gamma is inversely correlated with that of high mobility group box 1 (HMGB1, a late proinflammatory mediator) in patients with sepsis. Activation of PPAR gamma inhibits the basal and LPS-induced expression of HMGB1. The PPAR gamma-mediated inhibition of HMGB1 is associated with the upregulation of miR-142-3p, which can target the 3'-UTR of HMGB1, by directly binding to the PPRE in the miR-142-3p promoter region. Functional experiments reveal that the PPAR gamma-induced miR-142-3p suppresses inflammatory response in vivo. These results suggest that PPAR gamma-mediated upregulation of miR-142-3p inhibits the HMGB1 expression, which, in turn, is a novel anti-inflammatory mechanism of PPAR gamma and has an important role in the treatment of inflammatory diseases. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:158 / 164
页数:7
相关论文
共 50 条
  • [1] miR-142-3p Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Regulating HMGB1 Gene Expression
    Fu, Y.
    Sun, L-Q
    Huang, Y.
    Quan, J.
    Hu, X.
    Tang, D.
    Kang, R.
    Li, N.
    Fan, X-G
    CURRENT MOLECULAR MEDICINE, 2018, 18 (03) : 135 - 141
  • [2] MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1
    Liang, Lu
    Fu, Jijun
    Wang, Siran
    Cen, Huiyu
    Zhang, Lingmin
    Mandukhail, Safur Rehman
    Du, Lingran
    Wu, Qianni
    Zhang, Peiquan
    Yu, Xiyong
    ACTA PHARMACEUTICA SINICA B, 2020, 10 (06) : 1036 - 1046
  • [3] MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1
    Lu Liang
    Jijun Fu
    Siran Wang
    Huiyu Cen
    Lingmin Zhang
    Safur Rehman Mandukhail
    Lingran Du
    Qianni Wu
    Peiquan Zhang
    Xiyong Yu
    ActaPharmaceuticaSinicaB, 2020, 10 (06) : 1036 - 1046
  • [4] Regulation of miR-142-3p on the sensitivity of neuroblastoma cells to CDDP by targeting HMGB1
    Zhou, Xian-Jun
    Chen, Xin
    Lu, Yi
    Hao, Xi-Wei
    Zhang, Gang
    Zhang, Hong
    Duan, Yu-He
    Geng, Geng
    Dong, Qian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09): : 17239 - 17244
  • [5] Upregulation of miR-142-3p Improves Drug Sensitivity of Acute Myelogenous Leukemia through Reducing P-Glycoprotein and Repressing Autophagy by Targeting HMGB1
    Zhang, Yuan
    Liu, Yufeng
    Xu, Xueju
    TRANSLATIONAL ONCOLOGY, 2017, 10 (03): : 410 - 418
  • [6] Downregulation of circ-YES1 suppresses NSCLC migration and proliferation through the miR-142-3p–HMGB1 axis
    Mingming Jin
    Yan Wang
    Dawei Zhou
    Wanchao Liu
    Ruodong Han
    Yongbin Chi
    Respiratory Research, 24
  • [7] MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p
    Liu, Ke
    Huang, Jun
    Ni, Jiangdong
    Song, Deye
    Ding, Muliang
    Wang, Junjie
    Huang, Xianzhe
    Li, Wenzhao
    CELL CYCLE, 2017, 16 (06) : 578 - 587
  • [8] miR-142-3p and HMGB1 Are Negatively Regulated in Proliferation, Apoptosis, Migration, and Autophagy of Cartilage Endplate Cells
    Wang, Bo
    Ji, Demin
    Xing, Wenhua
    Li, Feng
    Huang, Zhi
    Zheng, Wenkai
    Xue, Jianmin
    Zhu, Yong
    Yang, Xuejun
    CARTILAGE, 2021, 13 (2_SUPPL) : 592S - 603S
  • [9] miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells
    Sharma, Priyanshu
    Yadav, Poonam
    Jain, Ruchi P.
    Bera, Amal Kanti
    Karunagaran, Devarajan
    LIFE SCIENCES, 2022, 291
  • [10] The Expression of miR-142-3p in Fatty Liver
    Henderson, Wendy A.
    Martino, Angela C.
    Del Valle-Pinero, Arseima Y.
    Peace, R. Michael
    Abey, Sarah
    GASTROENTEROLOGY, 2012, 142 (05) : S1021 - S1021